For: | Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005; 11(2): 289-292 [PMID: 15633234 DOI: 10.3748/wjg.v11.i2.289] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/289.htm |
Number | Citing Articles |
1 |
Xi Dai Long, Yun Ma, Hong Dong Huang, Jin Guang Yao, De Ying Qu, Yun Long Lu. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among guangxi population, China. Molecular Carcinogenesis 2008; 47(4): 295 doi: 10.1002/mc.20384
|
2 |
Tomasz Zemleduch, Margarita Lianeri, Małgorzata Rydzanicz, Marzena Gajęcka, Krzysztof Szyfter, Paweł P. Jagodziński. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Oral Oncology 2009; 45(8): 683 doi: 10.1016/j.oraloncology.2008.10.009
|
3 |
Jyh-Der Leu, I-Feng Lin, Ying-Fang Sun, Su-Mei Chen, Chih-Chao Liu, Yi-Jang Lee. Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population. World Journal of Gastroenterology 2009; 15(44): 5592-5597 doi: 10.3748/wjg.15.5592
|
4 |
Chang-Tao Xu, Fang Zheng, Xin Dai, Ji-Dong Du, Hao-Run Liu, Li Zhao, Wei-Min Li. Association Between TP53 Arg72Pro Polymorphism and Hepatocellular Carcinoma Risk: A Meta-analysis. Asian Pacific Journal of Cancer Prevention 2012; 13(9): 4305 doi: 10.7314/APJCP.2012.13.9.4305
|
5 |
Ze Tian, Geng Lin, Rui-Xia Zheng, Feng Huang, Meng-Su Yang, Pei-Gen Xiao. Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World Journal of Gastroenterology 2006; 12(6): 874-879 doi: 10.3748/wjg.v12.i6.874
|
6 |
Ayse Engin, Bensu Karahalil, Ali Karakaya, Atilla Engin. Association Between XRCC1 ARG399GLN and P53 ARG72PRO Polymorphisms and the Risk of Gastric and Colorectal Cancer in Turkish Population. Archives of Industrial Hygiene and Toxicology 2011; 62(3): 207 doi: 10.2478/10004-1254-62-2011-2098
|
7 |
Khadija Rebbani, Agnès Marchio, Sayeh Ezzikouri, Rajaa Afifi, Mostafa Kandil, Olfa Bahri, Henda Triki, Abdellah Essaid El Feydi, Anne Dejean, Soumaya Benjelloun, Pascal Pineau. TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0340-2
|
8 |
Maria Teresa Vietri, Gabriele Riegler, Antonietta Ursillo, Luigi Caserta, Michele Cioffi, Anna Maria Molinari. p53 codon 72 polymorphism in patients affected with ulcerative colitis. Journal of Gastroenterology 2007; 42(6): 456 doi: 10.1007/s00535-007-2026-z
|
9 |
Moqin Qiu, Yingchun Liu, Xiangyuan Yu, Linyuan Qin, Chunhua Bei, Xiaoyun Zeng, Xiaoqiang Qiu, Bo Tang, Songqing He, Hongping Yu. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma. Tumor Biology 2016; 37(3): 3863 doi: 10.1007/s13277-015-4222-4
|
10 |
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases. Tumor Biology 2014; 35(4): 3647 doi: 10.1007/s13277-013-1483-7
|
11 |
Yanmei Zou, Hua Xiong, Huihua Xiong, Tao Lu, Feng Zhu, Zhiyong Luo, Xianglin Yuan, Yihua Wang. A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2). Tumor Biology 2015; 36(7): 5179 doi: 10.1007/s13277-015-3172-1
|
12 |
D. Grotemeyer, S. Pourhassan, W. Sandmann. Paradigmenwechsel in der Behandlung des Wilkie-Syndroms. Der Internist 2009; 50(4): 484 doi: 10.1007/s00108-008-2263-0
|
13 |
C Ding, H Yu, H Yu, H Qin. TP53 Codon 72 Polymorphism with Hepatocellular Carcinoma: A Meta-Analysis. Journal of International Medical Research 2012; 40(2): 446 doi: 10.1177/147323001204000206
|
14 |
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: Possible implications on survival. Journal of Hepatology 2012; 57(3): 621 doi: 10.1016/j.jhep.2012.04.039
|
15 |
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases. Meta Gene 2013; 1: 126 doi: 10.1016/j.mgene.2013.09.010
|
16 |
Narayan Dharel, Naoya Kato, Ryosuke Muroyama, Masaru Moriyama, Run-Xuan Shao, Takao Kawabe, Masao Omata. MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C. Clinical Cancer Research 2006; 12(16): 4867 doi: 10.1158/1078-0432.CCR-06-0111
|
17 |
Luis Orlando Pérez, Martin Carlos Abba, Fernando Noel Dulout, Carlos Daniel Golijow. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World Journal of Gastroenterology 2006; 12(9): 1426-1429 doi: 10.3748/wjg.v12.i9.1426
|
18 |
Ahmet Taner Sümbül, Hikmet Akkız, Süleyman Bayram, Aynur Bekar, Ersin Akgöllü, Macit Sandıkçı. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case–control study. Molecular Biology Reports 2012; 39(2): 1639 doi: 10.1007/s11033-011-0903-2
|
19 |
Ken C. Lo, Dione Bailey, Tania Burkhardt, Paul Gardina, Yaron Turpaz, John K. Cowell. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. Genes, Chromosomes and Cancer 2008; 47(3): 221 doi: 10.1002/gcc.20524
|
20 |
Xiaohua Duan, Jingquan Li. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk. Medicine 2017; 96(36): e7856 doi: 10.1097/MD.0000000000007856
|
21 |
Mustafa A. Neamatallah, Mohamed Amr El-Missiry, Muhamad M.A. Said, Mahmoud Elbendary, Azza I. Othman, Omar A. Ammar. TP53 polymorphism as a risk factor for hepatocellular carcinoma in hepatitis C virus-infected Egyptian patients. Egyptian Journal of Basic and Applied Sciences 2014; 1(1): 9 doi: 10.1016/j.ejbas.2014.01.001
|
22 |
Y. J. Yoon, H. Y. Chang, S. H. Ahn, J. K. Kim, Y. K. Park, D. R. Kang, J. Y. Park, S. M. Myoung, D. Y. Kim, C. Y. Chon, K.-H. Han. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 2008; 29(6): 1192 doi: 10.1093/carcin/bgn090
|
23 |
Janet Edrington, Christine Miaskowski, Marylin Dodd, Candice Wong, Geraldine Padilla. A Review of the Literature on the Pain Experience of Chinese Patients With Cancer. Cancer Nursing 2007; 30(5): 335 doi: 10.1097/01.NCC.0000290813.14571.65
|
24 |
Liu Liu, Kai Wang, Zheng-Ming Zhu, Jiang-Hua Shao. Associations Between P53 Arg72Pro and Development of Digestive Tract Cancers: A Meta-analysis. Archives of Medical Research 2011; 42(1): 60 doi: 10.1016/j.arcmed.2011.01.008
|
25 |
K. N. Kashkin, S. V. Khlgatian, O. V. Gurova, D. V. Kuprash, S. A. Nedospasov. New mutations in the human p53 gene — a regulator of the cell cycle and carcinogenesis. Biochemistry (Moscow) 2007; 72(3): 282 doi: 10.1134/S0006297907030054
|
26 |
Shu-Chun Chuang, Yuan-Chin Amy Lee, Guo-Jie Wu, Kurt Straif, Mia Hashibe. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes & Control 2015; 26(9): 1205 doi: 10.1007/s10552-015-0615-3
|
27 |
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B. Hepatology 2014; 59(5): 1912 doi: 10.1002/hep.26655
|